Latest Regulatory Clearance News

Artrya Limited has begun generating fee-per-scan revenues from its Salix Coronary Plaque module at Tanner Health in the U.S., marking a key commercial milestone for the AI-powered cardiac imaging platform.

LTR Pharma has received regulatory clearance from the Therapeutic Goods Administration to commence its Phase II clinical trial of SPONTAN, focusing on men aged 65 and over. Patient recruitment is set to begin early next year, aiming to address a key gap in erectile dysfunction treatment.

Memphasys is intensifying its direct sales efforts for the Felix™ sperm-selection device across key Middle East IVF clinics, positioning for rapid market activation upon CE Mark approval expected early 2026.

National Storage REIT has entered a definitive agreement to be acquired by a Brookfield and GIC-led consortium for $2.86 per security, valuing the company at $4 billion. The Board unanimously recommends the scheme, pending shareholder and regulatory approvals.

Prominence Energy has secured the last regulatory approval needed to complete its acquisition of the Gawler Hydrogen Project, setting the stage for exploration of natural hydrogen in South Australia.

Helloworld Travel has secured crucial ACCC approval for its proposed acquisition of Webjet, advancing its plan to consolidate travel distribution in Australia and New Zealand.

African Gold Limited has entered into a binding agreement for acquisition by Montage Gold Corp. in an all-scrip deal valuing African Gold at a significant premium. The transaction aims to combine key Côte d’Ivoire gold assets under one larger entity.

Locksley Resources has kicked off its maiden drilling at the El Campo Rare Earths Prospect and secured full regulatory approval for an expanded program at the Desert Antimony Mine, setting the stage for continuous exploration updates through mid-2026.

Anteris Technologies Global Corp. has filed a Form S-1 registration statement with the SEC to enable resale of shares issued in a recent private placement, marking a key step in advancing its DurAVR transcatheter heart valve system and pivotal clinical trials.

PainChek Ltd has secured FDA De Novo clearance for its Adult App, marking a pivotal entry into the US long-term care market and setting the stage for global expansion including its Infant App.

Invictus Energy updates progress on its AMOG joint venture with Al Mansour Holdings, revealing ongoing negotiations for a significant Qatari ownership stake and deferral of a key placement settlement.

Infomedia Ltd has announced a fully franked special dividend of 2.9 cents per share, payable in late November, linked to its pending acquisition by McQueen BidCo Pty Ltd.